课题基金 / 基金详情

BetaCatenin Regulation of Skeletal Muscle Hypertrophy

BetaCatenin Regulation of Skeletal Muscle Hypertrophy
β连环蛋白对骨骼肌肥大的调节
批准号:
8500216
负责人:
Karyn A Esser
金额:
$31.74万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2017-06-30

项目摘要

项目成果

Karyn A Esser的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): As the "house-building" macromolecule of the cell, ribosome biogenesis is essential for cell growth. Despite this central role in cell growth, there remains a fundamental gap in our understanding of the role of ribosome biogenesis in adult skeletal muscle hypertrophy. Studies from our laboratory have provided evidence which supports a role for increased ribosome biogenesis in skeletal muscle hypertrophy. The current proposal will begin to directly examine the importance of ribosome biogenesis to muscle hypertrophy by testing the hypothesis that -catenin is necessary for muscle hypertrophy by increasing protein synthesis through c-myc activation of ribosome biogenesis. To conditionally, manipulate -catenin or c-myc gene expression in adult skeletal muscle we generated the HSA-MerCreMer mouse. Aim 1 will determine if ¿-catenin expression is necessary for skeletal muscle hypertrophy using a mechanical overload model of the plantaris muscle following catenin gene inactivation. Aim 2 will determine if increased expression of ¿-catenin is sufficient to stimulate skeletal muscle hypertrophy. ¿-catenin will be over-expressed in adult skeletal muscle by using the HSA- MerCreMer strain to generate a stabilized form of ¿-catenin. Aim 3 will determine if c-myc expression is necessary for skeletal muscle hypertrophy following the conditional inactivation of c-myc in adult skeletal muscle using the HSA-MerCreMer strain. The effect of gene inactivation on the hypertrophic response will be assessed by measuring morphometric (muscle weight, fiber CSA), biochemical (total protein, RNA and DNA), molecular (Western blot, RT-PCR, promoter analysis, chromatin immunoprecipitation (ChIP) and electrophorectic mobility shift assay (EMSA)) and metabolic (rates of protein synthesis and degradation) variables. The results of the proposed studies are expected to have important clinical implications by identifying new molecular targets for promoting skeletal muscle protein synthesis and hypertrophy. In the long- term, the ability to manipulate ribosome biogenesis represents a promising novel strategy to attenuate or ameliorate muscle atrophy associated with aging, bed rest and cachexia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MoTrPAC Supplemental Funding for Miller
  • 批准号:
    10889549
  • 项目类别:
  • 资助金额:
    $6.51万
  • 财政年份:
    2023
  • 负责人:
    Karyn A Esser
  • 依托单位:
Muscle clock and weakness: diversity supplement
  • 批准号:
    10414186
  • 项目类别:
  • 资助金额:
    $3.73万
  • 财政年份:
    2021
  • 负责人:
    Karyn A Esser
  • 依托单位:
Circadian Clock and Muscle Health
  • 批准号:
    10372227
  • 项目类别:
  • 资助金额:
    $52.98万
  • 财政年份:
    2021
  • 负责人:
    Karyn A Esser
  • 依托单位:
Circadian Clock and Muscle Health
  • 批准号:
    10583484
  • 项目类别:
  • 资助金额:
    $54.35万
  • 财政年份:
    2021
  • 负责人:
    Karyn A Esser
  • 依托单位:
海外基金